| LYFCX | THISX | LYFCX / THISX | |
| Total Expense Ratio | 2.46 | 0.67 | 367% |
| Annual Report Gross Expense Ratio | 2.88 | 0.67 | 430% |
| Fund Existence | 6 years | 10 years | - |
| Gain YTD | 28.618 | 18.103 | 158% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 500000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 37.5M | 12.6B | 0% |
| Annual Yield % from dividends | 0.90 | 0.15 | 593% |
| Returns for 1 year | 20.10 | -2.89 | -696% |
| Returns for 3 years | 24.59 | -0.72 | -3,402% |
| Returns for 5 years | 8.61 | -7.40 | -116% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IJUN | 28.73 | 0.11 | +0.38% |
| Innovator Intl Dev Pwr Bffr ETF - Jun | |||
| NMZ | 10.62 | 0.02 | +0.19% |
| Nuveen Municipal High Income Opportunity Fund | |||
| IFLO | 28.08 | 0.05 | +0.19% |
| VictoryShares Intl Free Csh Flow ETF | |||
| PPIE | 28.56 | 0.05 | +0.17% |
| Putnam PanAgora ESG Intl Eq ETF | |||
| IBBQ | 28.22 | -0.17 | -0.59% |
| Invesco Nasdaq Biotechnology ETF | |||